We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
An Indian pharmacists group is urging the government to immediately require detailed instructions on storage temperatures on all drug labels, to prevent improper handling in the supply chain and by end users. Read More
A drug safety committee in the EU wants manufacturers of ibuprofen to update their labeling to warn patients of a slightly increased risk of cardiovascular death when the painkiller is taken in high doses. Read More
The FDA is offering a grant of up to $1 million to turn large amounts of electronic health record data into usable figures highlighting postmarket risks of various drugs. The goal is for the agency to be able to perform continuous risk/benefit assessments of drugs after they hit the market. Read More
A drug safety committee in the EU is recommending that manufacturers of ibuprofen be required to warn patients that taking the painkiller in high doses is associated with an increased risk of cardiovascular death. Read More
Baxter International issued its sixth recall of intravenous solutions since December 2013, recalling 15 lots — about 237,000 units — because of the potential presence of particulate matter. Read More